Skip to content

Novel use of Erector spinae block during laparoscopic surgeries

Efficacy of erector spinal block during laparoscopic surgeries

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036754
Enrollment
50
Registered
2021-09-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Efficacy of erector spinal block during laparoscopic surgeries: 25 patients will be given ultrasound guided erector spinae block using 0.25% bupivacaine 20ml bilaterally at T5 Spinous p

Sponsors

DrDYpatil medical collegehospital and research centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Asa grade 1 and 2 Patients undergoing laparoscopic surgeries under general anaesthesia Haemodynamically stable patients with all routine investigations within normal limits without comorbidities Patients not on any cardiac related drugs

Exclusion criteria

Exclusion criteria: Asa 3 or more Patients posted for emergency procedure Major neurological,cardiac,respiratory,metabolic,renal,hepatic diseases with coagulation abnormalities Cardiac comorbidities Patients refusal

Design outcomes

Primary

MeasureTime frame
To determine the effectiveness of erector spinae block for haemodynamic stability during laparoscopic surgeriesTimepoint: Heart rate, systolic and diastolic blood pressure will be monitored at baseline, at induction of pneumoperitoneum, and every 10 mins thereafter untill the completion of surgery

Secondary

MeasureTime frame
The amount of Fentanyl required intraoperatively and the amount of inhalational agent required intraoperatively will be measured.Timepoint: The amount of fentanyl required intraoperatively, given in aliquots whenever heart rate or blood pressure increases 20% above the baseline values will be recorded for the duration of surgery. The amount of inhalational agent (Isoflurane) used intraoperatively during the period of surgery will be measured.

Countries

India

Contacts

Public ContactSumedha Biswas

Dr.D.Y. Patil medical college,hospital and research centre

biswasumedha@gmail.com9094042623

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026